Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
DKUFzq7wPkaWLRY1
